Pulling SEC filings + quote and writing the call…

Agape ATP Corp
Next earnings Aug 11, 2026
Chronically unprofitable nano-cap burning $2.4M/yr with just $140K cash — the $22.5M equity is paper, not liquidity. Uninvestable.
Cash & equivalents $140K · FY2025
ATPC is a $2.83M-market-cap nano-cap that has lost money every single year on record — net income of -$2.52M (FY21), -$1.69M, -$2.10M, -$2.47M and -$2.28M (FY25) — against a revenue base that has never cleared $1.9M and actually sits below its FY22 peak. Gross margin is a healthy-looking 55.0%, but operating margin is -213.7% and net margin -149.6%: the cost problem is entirely below the gross line (corporate overhead swamping a tiny top line), and FY25 operating income deteriorated another -26.6% to -$3.26M. This is a going-concern-style burn, not a growth story with a path to scale.
The balance sheet is the trap. On paper it looks pristine — equity up 1062% to $22.5M and liabilities/equity of just 0.10x — but cash fell 93.1% to $140K while current assets ballooned 774.8% to $24.3M and total assets jumped 659%. In other words, the entire equity build-up is non-cash: a $24M+ current asset that is NOT cash sitting against a company that burned -$2.41M of operating cash flow last year. With $140K of actual cash and a $2.4M annual burn, ATPC is dependent on converting or financing that paper asset immediately; the equity number tells you nothing about its ability to fund next quarter's payroll. Accumulated deficit is -$11.8M and worsening.
Is ATPC a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.02M | $1.86M | $1.43M | $1.32M | $1.52M |
| Gross profit | $720K | $1.19M | $937K | $759K | $838K |
| Operating income | -$1.86M | -$1.53M | -$2.15M | -$2.57M | -$3.26M |
| Net income | -$2.52M | -$1.69M | -$2.10M | -$2.47M | -$2.28M |
| Diluted EPS | — | -$0.02 | -$0.55 | -$31.74 | -$2.85 |
| Net margin | -248.2% | -90.9% | -146.9% | -186.8% | -149.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Filed S-1 to register new shares — potential dilution
Q1'26: continued operating losses; balance sheet bolstered by prior raise
FY25 revenue +15% to $1.52M on wellness/green-energy pivot; net loss $2.3M
Filed late-filing notice (12b-25) for FY25 10-K
Another Nasdaq continued-listing deficiency notice (Item 3.01)
Entered a new material definitive agreement
Filed shelf registration enabling future securities sales
Filed shelf registration enabling future securities sales
Disclosed Nasdaq listing-deficiency notice
Sources: SEC EDGAR (CIK 0001713210, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/4/2026, 10:26:29 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 6:26 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
1195 tracked peers · median